Clonal deletion in the thymus is the mechanism by which T cells recognizing autologous autologous MHC class II antigens, Mls antigens, and the male H-Y antigen are regulated. However, our studies of transgenic mice expressing physiological levels of human insulin indicate that tolerance is not maintained by clonal deletion. These observations support the idea that additional mechanisms operate in the peripheral immune system to maintain unresponsiveness of autoreactive T cells not deleted in the thymus. Using transgenic mice expressing the human insulin gene, we will dissect the mechanisms that maintain peripheral tolerance. To this end, we will determine: 1) whether insulin-specific Th cells are anergic in transgenic mice; 2) the role of Ts cells in tolerance expressed by transgenic mice; 3) whether human insulin-specific CTL can be stimulated in transgenic recipients of nontransgenic T cells; and, 4) if there is evidence for clonal deletion of high avidity T cells in transgenic mice. The second goal of this project is to determine why clonal deletion in the thymus is not effective for circulating autoantigens such as insulin. We hypothesize that clonal deletion of T cells in the thymus is antigen dose-dependent and that the concentration of insulin which reaches the thymus in these transgenic mice is insufficient to cause clonal deletion. A prediction of this hypothesis is that increasing the levels of insulin in the circulation will result in clonal deletion of human insulin-specific T cells. This will be assessed using transgenic mice expressing human insulin under the regulation of the metallothionein promoter or the I-E alpha promoter. The lessons learned from these studies may provide new approaches to the treatment of autoimmune diseases. Thus, our studies will be extended to an immunological disease model of Experimental Allergic Encephalomyelitis (EAE). This system will be used to address the circumstances in which peripheral mechanisms of maintaining self-tolerance fail and whether regulation can be re-instated once the disease occurs. These model systems are particularly relevant for the understanding of autoimune diseases in man in which there is evidence that auto-reactive T cells, present in the peripheral immune system, can escape from the normal regulatory mechanisms. Accumulating evidence suggests that autoimmunity may be involved in the pathogenesis of AIDS. Thus, our studies may be relevant toward understanding the immune dysfunction operating in AIDS and lead to the designing of therapeutic approaches for its treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
7R01AI013987-18
Application #
2060027
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1993-04-01
Project End
1994-11-30
Budget Start
1993-04-01
Budget End
1994-11-30
Support Year
18
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Emory University
Department
Pathology
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Ma, H; Ke, Y; Li, Q et al. (2000) Bovine and human insulin activate CD8+-autoreactive CTL expressing both type 1 and type 2 cytokines in C57BL/6 mice. J Immunol 164:86-92
Long, S A; Zimecki, M; Kapp, J A (1999) Bovine insulin and porcine or human insulin prime distinct CD4(+) T cell subsets in C57BL/6 mice. Cell Immunol 195:66-74
Dombrowski, K E; Brewer, K A; Maleckar, J R et al. (1997) Identification and partial characterization of ectoATPase expressed by immortalized B lymphocytes. Arch Biochem Biophys 340:10-8
Ke, Y; Kapp, J A (1996) Exogenous antigens gain access to the major histocompatibility complex class I processing pathway in B cells by receptor-mediated uptake. J Exp Med 184:1179-84
Zimecki, M; Mazurier, J; Spik, G et al. (1996) Lactoferrin inhibits proliferative response and cytokine production of TH1 but not TH2 cell lines. Arch Immunol Ther Exp (Warsz) 44:51-6
Ke, Y; Kapp, J A (1996) Oral antigen inhibits priming of CD8+ CTL, CD4+ T cells, and antibody responses while activating CD8+ suppressor T cells. J Immunol 156:916-21
Zimecki, M; Kapp, J A (1995) Presentation of antigen by B cell subsets. V. Effect of interleukin 7 (IL-7) and interleukin 10 (IL-10) on phenotype and antigen presenting function of immature B cells. Arch Immunol Ther Exp (Warsz) 43:253-7
Ke, Y; Li, Y; Kapp, J A (1995) Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses. Eur J Immunol 25:549-53
Dombrowski, K E; Ke, Y; Thompson, L F et al. (1995) Antigen recognition by CTL is dependent upon ectoATPase activity. J Immunol 154:6227-37
Kapp, J A; Pierce, C W; Webb, D R et al. (1995) Characterization of the epitope recognized by a mAb that reacts differentially with murine suppressor T cells. Int Immunol 7:1319-30

Showing the most recent 10 out of 38 publications